Discover 2,007 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,007
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Location: Fort Lauderdale FL, Miami Lakes FL, Merritt Island FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 45 - 70+
Code: NCT07613294
Phase 3, Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
for
Peripheral Arterial Disease
Location: Fort Lauderdale FL, Miami FL, Jacksonville FL,
Sponsor: Nipro Vascular Innovations Americas, Inc
Sex: All
Age: 18+
Code: NCT06321575
Recruiting
Treatment of Calcific Total Occlusions in Peripheral Artery Disease
for
Chronic Total Occlusion of Artery of the Extremities
Location: Fort Lauderdale FL, Providence RI
Sponsor: SoundBite Medical Solutions, Inc.
Sex: All
Age: 19+
Code: NCT05551780
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Fort Lauderdale FL, Springfield OR, St. Petersburg FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Location: Fort Lauderdale FL, West Columbia SC, Hagerstown MD,
Sponsor: Ocular Therapeutix, Inc.
Sex: All
Age: 50+
Code: NCT07516132
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Fort Lauderdale FL, St. Petersburg FL, Charleston SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Fort Lauderdale FL, St. Petersburg FL, Charleston SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Location: Fort Lauderdale FL, Melbourne FL, Tampa FL,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT05197270
Phase 1, Phase 2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Fort Lauderdale FL, Coral Springs FL, Springfield OR,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase 3, Recruiting
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
for
NSCLC, Non-small Cell Lung Cancer,
Location: Fort Lauderdale FL, Plantation FL, Anchorage AK
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07777822
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Fort Lauderdale FL, Miami Lakes FL, Miami FL,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
for
Systemic Lupus Erythematosus (SLE)
Location: Fort Lauderdale FL, Hollywood FL, Margate FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 16+
Code: NCT07175285
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Location: Fort Lauderdale FL, Hollywood FL, Pembroke Pines FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07355218
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Pompano Beach FL, Hollywood FL, Miami Lakes FL,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Location: Plantation FL, Miami FL, Greenacres City FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07607964
Phase 1, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)